BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19309718)

  • 21. Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus.
    Cengiz P; Zemlan F; Ellenbogen R; Hawkins D; Zimmerman JJ
    Pediatr Crit Care Med; 2008 Sep; 9(5):524-9. PubMed ID: 18679140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
    Vlacha V; Eliopoulou M; Haidas S; Beratis NG
    Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
    Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
    Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
    Gavhed D; Akefeldt SO; Osterlundh G; Laurencikas E; Hjorth L; Blennow K; Rosengren L; Henter JI
    Pediatr Blood Cancer; 2009 Dec; 53(7):1264-70. PubMed ID: 19688833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-induced oral complications in leukemic patients.
    de Oliveira Lula EC; de Oliveira Lula CE; Alves CM; Lopes FF; Pereira AL
    Int J Pediatr Otorhinolaryngol; 2007 Nov; 71(11):1681-5. PubMed ID: 17850887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia.
    Nakagawa K
    Cell Mol Biol (Noisy-le-grand); 2000 Dec; 46(8):1375-81. PubMed ID: 11156482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia.
    Lönnerholm G; Thörn I; Sundström C; Frost BM; Abrahamsson J; Behrendtz M; Heldrup J; Jacobsson S; Li A; Olofsson T; Porwit A; Söderhäll S; Larsson R; Forestier E
    Leuk Res; 2009 Jan; 33(1):46-53. PubMed ID: 18639340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of chemotherapy for acute lymphoblastic leukemia on the medial olivocochlear bundle: effects of different cumulative doses of gentamicin.
    Riga M; Korres S; Varvutsi M; Kosmidis H; Douniadakis D; Psarommatis I; Yiotakis I; Ferekidis E
    Int J Pediatr Otorhinolaryngol; 2007 Nov; 71(11):1767-73. PubMed ID: 17884185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau.
    Elens I; Deprez S; Danckaerts M; Bijttebier P; Labarque V; Uyttebroeck A; Van Gool S; D'Hooge R; Lemiere J
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia.
    Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
    Klin Padiatr; 2008; 220(6):388-90. PubMed ID: 18949677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptosporidiosis in children with acute lymphoblastic leukemia on maintenance chemotherapy.
    Domenech C; Rabodonirina M; Bleyzac N; Pagès MP; Bertrand Y
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):570-2. PubMed ID: 21941152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is there a correlation between the cerebrospinal fluid changes and EEG findings in children with acute leukemia?].
    Osuch Z; Korwin-Piotrowska T
    Wiad Lek; 1988 Mar; 41(5):291-4. PubMed ID: 3218236
    [No Abstract]   [Full Text] [Related]  

  • 35. Creatinine as a measure of lean body mass during treatment of acute lymphoblastic leukemia in childhood.
    Morrison J; Nayiager T; Webber CE; Sala A; Barr R
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e13-6. PubMed ID: 21178703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
    Kaya Z; Gursel T; Bakkaloglu SA; Kocak U; Atasever T; Oktar SO
    Pediatr Hematol Oncol; 2007 Jun; 24(4):257-67. PubMed ID: 17613868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
    Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
    Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
    Ryan J; Quinn F; Meunier A; Boublikova L; Crampe M; Tewari P; O'Marcaigh A; Stallings R; Neat M; O'Meara A; Breatnach F; McCann S; Browne P; Smith O; Lawler M
    Br J Haematol; 2009 Jan; 144(1):107-15. PubMed ID: 19016726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of lactate dehydrogenase isoenzyme in the cerebrospinal fluid of patients with acute lymphoblastic leukemia].
    Lesnichenko IF; Gubarenko NK; Gritsaev SV; Salmykova NB; Blinov MN
    Vopr Onkol; 2008; 54(1):59-61. PubMed ID: 18416059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.